Alerts will be sent to your verified email
Verify Email
MERCURYLAB
|
Mercury Laboratories
|
Vaishali Pharma
|
Guj. Inject (Kerala)
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.51 % | 7.83 % | 1.55 % |
|
5yr average Equity Multiplier
|
1.49 | 2.48 | 0.11 |
|
5yr Average Asset Turnover Ratio
|
1.05 | 0.88 | 0.45 |
|
5yr Avg Net Profit Margin
|
6.6 % | 3.68 % | -175.28 % |
|
Price to Book
|
1.76 | 1.5 | 8.96 |
|
P/E
|
20.75 | 0.0 | 361.85 |
|
5yr Avg Cash Conversion Cycle
|
-4.69 Days | 87.63 Days | -14.62 Days |
|
Inventory Days
|
32.68 Days | 6.87 Days | 38.61 Days |
|
Days Receivable
|
115.65 Days | 177.19 Days | 0.0 |
|
Days Payable
|
157.73 Days | 159.49 Days | 156.02 Days |
|
5yr Average Interest Coverage Ratio
|
15.15 | 2.55 | 298.1 |
|
5yr Avg ROCE
|
13.49 % | 15.65 % | 2.0 % |
|
5yr Avg Operating Profit Margin
|
11.74 % | 5.99 % | -279.73 % |
|
5 yr average Debt to Equity
|
0.13 | 0.48 | -0.62 |
|
5yr CAGR Net Profit
|
-10.08 % | -4.82 % | n/a |
|
5yr Average Return on Assets
|
7.02 % | 3.24 % | -116.01 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.66 % | 31.61 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 4.87 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Mercury Laboratories
|
Vaishali Pharma
|
Guj. Inject (Kerala)
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|